THE RECENT publications of Farber and co-workers dealing with the treatment of acute leukemia in children have awakened widespread interest. Their investigations have stimulated hope for the amelioration of symptoms of this fatal disease and indicated the possibility of provoking remissions that lengthen the lives of those patients affected by it, while making them more comfortable at the same time. In investigating leukemia and allied conditions of a neoplastic nature, Farber and co-workers noted what they termed an "acceleration phenomenon" in the blood and bone marrow of leukemic children treated with folic acid or its conjugates such as diopterin (pteroyldiglutamic acid) or teropterin (pteroyltriglutamic acid). There was marked hyperplasia of the marrow as well as of other sites of leukemic involvement at postmortem examination. They reasoned that if folic acid or its conjugates speeded up the leukemic process, an antagonist to folic acid might be devised in order to retard the progress of the disease or stop it altogether. Through co-operation with the research division of one of the major pharmaceutical firms, a series of folic acid antagonists was soon developed. One of these was aminopterin (4-aminopteroylglutamic acid). It differs from folic acid only in the substitution of the NH2 group for the OH radical in the fourth position of the pteridine group. Of several compounds synthetically made, it has been the most effective and yet most toxic agent in its action on the leukemic process. Farber and co-workers first employed aminopterin in the treatment of acute leukemia of children in December 1947.
To the Editor.— The cases reported by Olson et al1 of pulmonary hemorrhage in children with systemic vasculitis clearly highlight the fact that children are not "immune" to these conditions. We must take issue, however, with the diagnosis of Henoch-Schönlein purpura in the patients described. Because Henoch-Schönlein purpura is a subset of systemic vasculitis, the clinical manifestations may mimic or be mimicked by other vasculitis syndromes such as polyarteritis nodosa, Wegener's granulomatosis, and systemic lupus erythematosus.2
Salicylate is a potent pharmacologic agent, and the rational therapy of salicylate intoxication must be based on an understanding of its pharmacologic actions and consequent pathophysiologic effects.l Because it acts to uncouple oxidative phosphorylation in a manner analogous to that of 2,4-dinitrophenol, salicylate is, first of all, a general metabolic stimulant.2 Oxygen consumption, carbon dioxide formation, and heat production are increased by its action; consequently, oxygen requirement, blood CO2 concentration, and the need to eliminate heat are also increased. Respiration, heart rate, and cardiac output must increase to satisfy the demands imposed by the acceleration of metabolic processes. Second, saiicylate interferes in a complex manner with the normal metabolism of carbohydrate.3 Many factors seem to be involved, some tending to decrease and others to increase the blood glucose concentralion, and, clinically, either hyperglycemia or hypoglycemia may be observed. Hyperglycemia may be partially explained by the release of epinephrmne due to activation of hypothalamic sympathetic centers. However, large doses of salicyiate also decrease aerobic metabolism and increase glucose-6-phosphatase activity, effects which tend to increase the blood glucose level. Hypoglycemia, on the other hand, may be caused by an increased utilization of glucose by peripheral tissues or by interference with gluconeogenesis by salicylates. Recent studies suggest that brain glucose concentration may be decreased despite minimal alterations in blood glucose level.4 As a result of these salicylate-mnduced alterations in carbohydrate metabolism, organic acids, particularly lactic, pyruvic, and acetoacetic, accumuiate.5 Infants appear to be particularly susceptible to the toxic effects of salicylate on carbohydrate metabolism and are more likely to have disturbances in blood glucose concentration and metabolic acidosis than are older children.
Follow-up letters were received from 336 asthmatic patients who had been examined at the Mayo Clinic 17 to 27 years previously. There was a ratio of two male patients to one female. The age of onset of asthma was less than 5 years in 65% of patients. Forty-eight per cent of patients reported that they had wheezing at the time of follow-up. There was essentially no difference between those who had an early onset of asthma and those who had a later onset. Of patients who had had associated eczema, 54% reported wheezing in the preceding year in contrast to 42% of those who had had no associated allergic disease. Of the group having had allergic rhinitis, 48% reported wheezing at the time of follow-up; this also was the average for the total group. When patients were divided into groups according to present age, a tendency was revealed for male patients to improve with age. This was not true of female patients.
AMERICAN ACADEMY OF PEDIATRICS, INC. PROCEEDINGS AND REPORTS
PERIODICALLY, it appears to be appropriate and perhaps even necessary to pause for a moment to consider the question, "Where are we going and by what means are we moving along our course?" In the case of the Academy, the answers are to be found in a consideration of the present structure and activities of the components of the group. A very brief, even categorical review of the committees, liaison representatives and official subdivisions will tell us much, and will serve to remind us that we are participants in a great vital program dedicated to the health and welfare of children. Let us first consider the aims and activities of the various committees of the Academy. In the past few years, an increasing awareness of loss of child life through accidents has prompted the Committee on Accident Prevention to survey the causes and to initiate a program of prevention which has received nationwide attention. Unpleasant though it may be to contemplate the prospect of a world engaged in another holocaust of war, the need for preparedness has been recognized at all levels of our civil structure, and in consonance with the emphasis on national alertness, the Academy has established a Committee whose purpose it is to compile information as to the possible needs of children in wartime and the role that pediatricians can play in satisfying those needs, if the occasion demands it. During the lives of most of us, contagious and infectious diseases have become increasingly less common and less severe. In order that the most effective means of controlling, as well as treating, these diseases may be available to all, the Committee on Control of Infectious Diseases has issued and, at intervals, has revised a manual that contains the latest and most reliable information that can be supplied by a panel of experts in the field.
Birth Asphyxia Alters Neonatal Intestinal Motility in Term Neonates
As an extension of an earlier study showing that manometry can identify preterm newborns at risk for feeding intolerance, the authors investigated whether abnormalities of intestinal motor activity underlie the feeding intolerance seen in asphyxiated newborns. Low-compliance perfusion manometry was recorded within the first postnatal week in 25 term neonates admitted consecutively for respiratory diseases. Eleven of these neonates were identified to have experienced birth asphyxia because three concurrent features were present: 1-minute Apgar score of less than 2; 5-minute Apgar score of less than 4; and recurrent seizures within the first 48 postnatal hours. The remaining 14 neonates, who did not have any of these three characteristics, were considered to be nonasphyxiated control neonates. Motor activity differed in nonasphyxiated and asphyxiated neonates during fasting and feeding. During fasting, asphyxiated neonates had less migrating activity than nonasphyxiated neonates. In addition, episodes of motor quiescence and clustered phasic activity were less well organized in asphyxiated neonates. Both groups of neonates displayed a change in motor activity in response to a feeding infusion; however, the response was initiated significantly sooner in asphyxiated than in control neonates. All of the 11 asphyxiated neonates were intolerant of enteral feedings during the first poststudy week, but no control neonate was feeding intolerant. Six of the asphyxiated neonates were reevaluated 1 to 2 weeks later. During this latter study, motor activity in these asphyxiated neonates was similar to that of nonasphyxiated neonates; 5 of 6 of these neonates subsequently tolerated enteral feedings. It is speculated that changes in motor activity underlie the feeding intolerance that asphyxiated neonates typically exhibit. Furthermore, manometrics may provide a direct method to monitor functional responsiveness of the intestinal tract to identify those neonates at risk for feeding intolerance and to guide feeding management in these neonates.
NONTUBERCULOUS ACID-FAST BACILLI IN CERVICAL ADENITIS
THE TUBERCLE bacillus is the most common cause of lymphadenitis with caseous necrosis. Such a condition in the cervical region, while less frequent than in previous decades, still occurs occasionally. While other agents, for example, Coccidioides, Histoplasma, Brucella, Pasteurella and Miyagawanella, are known to produce a similar histopathologic reaction, they are not commonly associated with lesions in the cervical lymph nodes, especially in children. Therefore the finding of acid-fast bacilli in such lesions has generally been considered bona fide evidence of tuberculosis, although previous reports from this clinic indicate that such is not necessarily true. It is recognized that there are other acid-fast bacilli, such as the lepra and smegma bacilli, which may or may not cause disease. In 1944 Gellerstedt reported seven cases of tuberculoid skin lesions due to atypical acid-fast bacilli. He considered these to be due to exogenous infection with acid-fast bacilli differing from the organisms found in tuberculosis, and he considered them as possibly saprophytic organisms. In 1948 MacCallum and co-workers reported six cases of skin lesions due to acid-fast organisms that were not Mycobacterium tuberculosis. The lesions did not contain tubercle follicles, giant cells or caseous material. The name "Mycobacterium ulcerans" was applied to these organisms by Australian workers. In 1954 Linnell and Nordén described skin lesions that occurred in 80 boys and girls who used a certain swimming pool in a Swedish town. The etiologic organisms were acid fast, differed from those described by MacCallum and associates and were not lepra bacilli. Guinea pigs injected with these organisms presented no evidence of lesions after 7 weeks.
THE RELATIONSHIP OF FIBROCYSTIC DISEASE OF THE PANCREAS TO A DEFICIENCY OF SECRETIN
The theoretic considerations which indicate that fibrocystic disease of the pancreas is the result of a congenital deficiency of secretin have been outlined. The varied clinical and pathologic manifestations of this disease can, in our opinion, be more nearly adequately explained by this hypothesis than by any of the other current theories. The absence of secretin (S1) in the upper part of the intestinal tract of a patient with fibrocystic disease of the pancreas lends support to this theory; which is to say, that the condition is the result of a congenital deficiency of secretin. It has been shown to be possible to extract secretin from the upper part of the intestinal tract of persons two months to 73 years old. The only consistent, failures occurred in work with patients in the neonatal period. Successful extraction of secretin from these patients in the neonatal period can be carried out, however, by combining the crude extracts obtained from a number of patients. The extraction of secretin is successful if it is done up to 15 hours postmortem. If the specimen is kept in a frozen state, extraction can be delayed without loss of activity as long as 39 days. Because this method of extraction is successful in individual cases at necropsy, it becomes possible to correlate the presence or absence of secretin with varying pathologic conditions. This, in turn, may open up a broad field for the investigation of many pancreatic and intestinal disturbances in addition to fibrocystic disease of the pancreas.
In small children with nutritional vitamin D deficiency, the serum concentration of 25-hydroxyvitamin D (25-OH-D), the major circulating metabolite of vitamin D, was correlated with the stage of clinical disease. It was low (16 to 20 ng/ml) but within the normal range in the earliest (hypocalcemic) stage of the deficiency syndrome and decreased (< 15 ng/ml) in the more advanced stages. In patients with familial hypophosphatemia (X-linked dominant), mean serum 25-OH-D concentration was the same as in age-matched normal controls. Evidence is presented that endogenous parathyroid hormone may have a role in the depletion of serum 25-OH-D in deficiency states.
The April 1973 issue of Pediatrics contained a Letter to the Editor from Gerald B. Merenstein, M.D. In his letter, Dr. Merenstein was guilty of a fundamental error in the understanding of the mechanism of oxygen uptake by the tissues. Because this misconception is not uncommon, I believe that the topic deserves comment. Dr. Merenstein compared systemic arterial oxygen content of two neonates in a hypothetical example (he referred to oxygen content as oxygen capacity, but this error is relatively unimportant). His illustration was as follows: